Tempest Therapeutics
TPST
13 hedge funds and large institutions have $3.54M invested in Tempest Therapeutics in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.03% less ownership
Funds ownership: 2.27% → 2.24% (-0.03%)
19% less funds holding
Funds holding: 16 → 13 (-3)
34% less capital invested
Capital invested by funds: $5.36M → $3.54M (-$1.82M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.12K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$337 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$19K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5K |
| 3 |
Renaissance Technologies
New York
|
-$2.59K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$316 |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$127 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EC
1
EcoR1 Capital
San Francisco,
California
| $1.19M | – | – | – |
|
|
RSCM
2
Rock Springs Capital Management
Baltimore,
Maryland
| $947K | – | – | – |
|
3
Fidelity Investments
Boston,
Massachusetts
| $752K | – | – | – |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $277K | +$337 | +16 | +0.1% |
|
5
Fidelity International
Hamilton,
Bermuda
| $150K | – | – | – |
|
6
BlackRock
New York
| $95.5K | – | – | – |
|
|
7
Geode Capital Management
Boston,
Massachusetts
| $78K | -$316 | -15 | -0.3% |
|
|
8
Renaissance Technologies
New York
| $29K | -$2.59K | -123 | -6% |
|
9
Franklin Resources
San Mateo,
California
| $13.1K | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $8K | +$3.12K | +148 | +41% |
|
11
Morgan Stanley
New York
| $644 | – | – | – |
|
12
Wells Fargo
San Francisco,
California
| $78 | – | – | – |
|
13
Bank of America
Charlotte,
North Carolina
| $17 | – | – | – |
|
|
14
Millennium Management
New York
| – | -$19K | -843 | Closed |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$5K | -221 | Closed |
|
|
16
BNP Paribas Financial Markets
Paris,
France
| – | -$127 | -6 | Closed |
|
TPST Hedge Fund Activity: Q4 2022 in Review
13 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2022, worth a combined $3.54M — down 34% from $5.36M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of TPST and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $3.12K. The largest seller was Millennium Management, exiting entirely with an estimated $19K sold.
- 13 institutional investors held Tempest Therapeutics (TPST) as of Q4 2022, down from 16 in Q3 2022.
- Funds reported $3.54M of Tempest Therapeutics stock for Q4 2022, down 34% quarter-over-quarter.
- 0 funds opened new Tempest Therapeutics positions in Q4 2022 and 3 closed out, a net change of -3 holders.
- The largest Tempest Therapeutics buyer in Q4 2022 was Tower Research Capital (TRC), an estimated $3.12K added.
- The largest Tempest Therapeutics seller in Q4 2022 was Millennium Management, an estimated $19K sold.
Based on aggregated 13F filings for Q4 2022.